Related references
Note: Only part of the references are listed.Targeting Epigenetics in Lung Cancer
Yvonne L. Chao et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2021)
A CRISPR/Cas13a-powered catalytic electrochemical biosensor for successive and highly sensitive RNA diagnostics
Yan Sheng et al.
BIOSENSORS & BIOELECTRONICS (2021)
Single-cell lineages reveal the rates, routes, and drivers of metastasis in cancer xenografts
Jeffrey J. Quinn et al.
SCIENCE (2021)
Sensitive Detection of KRAS Mutations by Clustered Regularly Interspaced Short Palindromic Repeats
Huifen Zhou et al.
DIAGNOSTICS (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Rlf-Mycl Gene Fusion Drives Tumorigenesis and Metastasis in a Mouse Model of Small Cell Lung Cancer
Metamia Ciampricotti et al.
CANCER DISCOVERY (2021)
In Vivo Epigenetic CRISPR Screen Identifies Asf1a as an Immunotherapeutic Target in Kras-Mutant Lung Adenocarcinoma
Fei Li et al.
CANCER DISCOVERY (2020)
Opposing Functions of BRD4 Isoforms in Breast Cancer
Shwu-Yuan Wu et al.
MOLECULAR CELL (2020)
CRISPR screens in cancer spheroids identify 3D growth-specific vulnerabilities
Kyuho Han et al.
NATURE (2020)
Keap1 mutation renders lung adenocarcinomas dependent on Slc33a1
Rodrigo Romero et al.
NATURE CANCER (2020)
Synthetic Lethal Interaction of SHOC2 Depletion with MEK Inhibition in RAS-Driven Cancers
Rita Sulahian et al.
CELL REPORTS (2019)
Lung cancer epigenetics: From knowledge to applications
Michael Duruisseaux et al.
SEMINARS IN CANCER BIOLOGY (2018)
Highly Effective and Low-Cost MicroRNA Detection with CRISPR-Cas9
Xin-Yuan Qiu et al.
ACS SYNTHETIC BIOLOGY (2018)
ER Stress Signaling Promotes the Survival of Cancer Persister Cells Tolerant to EGFR Tyrosine Kinase Inhibitors
Hideki Terai et al.
CANCER RESEARCH (2018)
Cre-dependent Cas9-expressing pigs enable efficient in vivo genome editing
Kepin Wang et al.
GENOME RESEARCH (2017)
C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector
Omar O. Abudayyeh et al.
SCIENCE (2016)
Genome-wide CRISPR Screen in a Mouse Model of Tumor Growth and Metastasis
Sidi Chen et al.
CELL (2015)
Cpf1 Is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas System
Bernd Zetsche et al.
CELL (2015)
Genomic alterations in lung adenocarcinoma
Siddhartha Devarakonda et al.
LANCET ONCOLOGY (2015)
In vivo genome editing using Staphylococcus aureus Cas9
F. Ann Ran et al.
NATURE (2015)
CRISPR-Cas9 Knockin Mice for Genome Editing and Cancer Modeling
Randall J. Platt et al.
CELL (2014)
Comprehensive molecular profiling of lung adenocarcinoma
Eric A. Collisson et al.
NATURE (2014)
Rapid modelling of cooperating genetic events in cancer through somatic genome editing
Francisco J. Sanchez-Rivera et al.
NATURE (2014)
In vivo engineering of oncogenic chromosomal rearrangements with the CRISPR/Cas9 system
Danilo Maddalo et al.
NATURE (2014)
DNA interrogation by the CRISPR RNA-guided endonuclease Cas9
Samuel H. Sternberg et al.
NATURE (2014)
Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression
Lei S. Qi et al.
CELL (2013)
RNA-Guided Human Genome Engineering via Cas9
Prashant Mali et al.
SCIENCE (2013)
Multiplex Genome Engineering Using CRISPR/Cas Systems
Le Cong et al.
SCIENCE (2013)
A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity
Martin Jinek et al.
SCIENCE (2012)
Characterizing the cancer genome in lung adenocarcinoma
Barbara A. Weir et al.
NATURE (2007)
Intervening sequences of regularly spaced prokaryotic repeats derive from foreign genetic elements
FJM Mojica et al.
JOURNAL OF MOLECULAR EVOLUTION (2005)
Adjuvant and neoadjuvant therapy in prostate cancer
C Chay et al.
SEMINARS IN ONCOLOGY (2001)
Share Paper
